Literature DB >> 25040384

A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act.

Alison R Hwong1, Noor Qaragholi, Daniel Carpenter, Steven Joffe, Eric G Campbell, Lisa Soleymani Lehmann.   

Abstract

Under the Physician Payment Sunshine Act (PPSA), payments to physicians from pharmaceutical, biologics, and medical device manufacturers will be disclosed on a national, publicly available website. To inform the development of the federal website, we evaluated 21 existing state and industry disclosure websites. The presentation formats and language used suggest that industry websites are aimed at patient audiences whereas state websites are structured to transmit data to researchers and guide compliance officers. These findings raise questions about the intended audience and aims of the PPSA disclosure database and expected outcomes of the law. Based on our evaluation, we offer recommendations for the national website and discuss implications of this policy for the health care system.
© 2014 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25040384     DOI: 10.1111/jlme.12136

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  3 in total

1.  Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.

Authors:  Genevieve Pham-Kanter; Michelle M Mello; Lisa Soleymani Lehmann; Eric G Campbell; Daniel Carpenter
Journal:  J Gen Intern Med       Date:  2017-03-06       Impact factor: 5.128

Review 2.  Interventions to reduce corruption in the health sector.

Authors:  Rakhal Gaitonde; Andrew D Oxman; Peter O Okebukola; Gabriel Rada
Journal:  Cochrane Database Syst Rev       Date:  2016-08-16

Review 3.  Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.

Authors:  Deborah C Marshall; Madeleine E Jackson; Jona A Hattangadi-Gluth
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.